NeoGenomics Inc
NEO
$16.68-3.30%
Delayed · as of Oct 16, 2026, 11:30 AM ET
Mkt cap
$924.03M
EV/Sales
1.52
P/E ratio
N/A
FY2025 Revenue
$727.33M
EPS (FY2025)
N/A
Gross Margin (FY2025)
43.21%
Profit Margin (FY2025)
-14.85%
Beta
1.64
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported NEO revenue for 2025-12-31 was $727.3M. Net income was -$108.0M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. NEO currently screens at market cap $924.0M.
Use this NEO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NEO income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
NeoGenomics Inc (NEO) is a diagnostics & research company in the Healthcare sector.
Latest cached NeoGenomics Inc (NEO) revenue for Dec 31, 2025 was $727.3M. Net income was -$108.0M. Statements: https://lician.com/financials/neo
NeoGenomics Inc (NEO) market capitalization is $924.0M on the latest cached snapshot.
NeoGenomics Inc (NEO) cached previous close $17.25; day range $16.68 – $17.24; volume 289,162. Session quote: https://lician.com/quote/neo